TY - JOUR
T1 - Strong TCR conservation and altered T cell cross-reactivity characterize a B*57-restricted immune response in HIV-1 infection
AU - Gillespie, G M A
AU - Stewart-Jones, G
AU - Rengasamy, J
AU - Beattie, T
AU - Bwayo, J J
AU - Plummer, F A
AU - Kaul, R
AU - McMichael, A J
AU - Easterbrook, P
AU - Dong, T
AU - Jones, E Y
AU - Rowland-Jones, S L
PY - 2006/9/15
Y1 - 2006/9/15
N2 - HLA-B*57 is associated with slower disease progression to AIDS, and CD8(+) T cell responses to B*57-restricted epitopes are thought to contribute to this protective effect. In this study, we evaluate the B*57-restricted p24 KAFSPEVIPMF (KF11) immune response which is immunodominant during chronic infection. Previously, we observed that the KF11 clade variants KGFNPEVIPMF [A2G,S4N] and KAFNPEIIMPF [S4N,V71], sharing a position 4 mutation, are differentially recognized by KF11-specific T cells. By combining structural and cellular studies, we now demonstrate that the KF11 and [A2G,S4N] epitopes induce distinct functional responses in [A2G,S4N] and KF11-specific T cells, respectively, despite minimal structural differences between the individual B*57-peptide complexes. Recently, we also elucidated the highly distinct structure of KF11 in complex with B*5703, and have now characterized the CD8(+) T cell repertoire recognizing this epitope. We now report striking features of TCR conservation both in terms of TCR V alpha and V beta chain usage, and throughout the hypervariable region. Collectively, our findings highlight unusual features of the B*5701/B*5703-KF11-specific immune responses which could influence disease progression and that might be important to consider when designing future vaccine regimens
AB - HLA-B*57 is associated with slower disease progression to AIDS, and CD8(+) T cell responses to B*57-restricted epitopes are thought to contribute to this protective effect. In this study, we evaluate the B*57-restricted p24 KAFSPEVIPMF (KF11) immune response which is immunodominant during chronic infection. Previously, we observed that the KF11 clade variants KGFNPEVIPMF [A2G,S4N] and KAFNPEIIMPF [S4N,V71], sharing a position 4 mutation, are differentially recognized by KF11-specific T cells. By combining structural and cellular studies, we now demonstrate that the KF11 and [A2G,S4N] epitopes induce distinct functional responses in [A2G,S4N] and KF11-specific T cells, respectively, despite minimal structural differences between the individual B*57-peptide complexes. Recently, we also elucidated the highly distinct structure of KF11 in complex with B*5703, and have now characterized the CD8(+) T cell repertoire recognizing this epitope. We now report striking features of TCR conservation both in terms of TCR V alpha and V beta chain usage, and throughout the hypervariable region. Collectively, our findings highlight unusual features of the B*5701/B*5703-KF11-specific immune responses which could influence disease progression and that might be important to consider when designing future vaccine regimens
M3 - Article
SN - 1550-6606
VL - 177
SP - 3893
EP - 3902
JO - Journal of Immunology
JF - Journal of Immunology
IS - 6
ER -